论文部分内容阅读
目的:观察血凝酶局部雾化吸入对咯血的治疗效果。方法:选择2001年1月至2003年1月收入院住院的咯血患者61例,随机分为2组,治疗组31例,予以常规镇静、止血、抗感染的基础上予以雾化吸入血凝酶(2u)。对照组30例,仅给予常规镇静、止血、抗感染治疗。观察两组患者咯血停止时间。结果:治疗组31例,显效16例,有效13例,无效2例,总有效率93.5%。对照组:总有效率70.9%。差异有显著(p<0.05)。结论:血凝酶雾化吸入治疗咯血起效迅速,疗效确切,副作用小,值得推广。
Objective: To observe the therapeutic effect of haemocoagulase inhalation on hemoptysis. Methods: From January 2001 to January 2003, 61 hospitalized patients with hemoptysis were randomly divided into 2 groups and 31 patients in the treatment group. They were treated with routine sedation, hemostasis and anti-infection, (2u). Control group of 30 patients, only given routine sedation, hemostasis, anti-infective treatment. The duration of hemoptysis in both groups was observed. Results: The treatment group of 31 cases, markedly effective in 16 cases, effective in 13 cases, 2 cases, the total effective rate 93.5%. Control group: the total effective rate 70.9%. The difference was significant (p <0.05). Conclusion: Hemagglutination enzyme inhalation for the treatment of hemoptysis has rapid onset, definite curative effect and small side effects. It is worth popularizing.